iSpecimen Inc (ISPC): Market Cap to Revenue

Brandmark of iSpecimen Corp (ISPC)

The stability of iSpecimen Inc. (ISPC) is underpinned by its streamlined online logistics for biomaterials, as evidenced by the current P/S ratio, which stands at 3.70. The company has developed a unique tissue marketplace to accelerate pharmacological research. However, national digital sovereignty and technological nationalism could limit the global expansion of iSpecimen Inc. (ISPC) software, creating risks of business fragmentation.

ISPC iSpecimen Corp Price-to-Revenue Ratio (07/04/2022 - 11/13/2026)

Analytical breakdowns for iSpecimen Inc. (ISPC)

- price and consensus price forecast:
Market Chart ispecimen.com|ISPC - Price Target Chart
- stock exchange capitalization data:
Market Valuation iSpecimen Corp|ISPC - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share iSpecimen|ISPC - Company Book Value|Capitalization to Book Value Ratio ispecimen.com|ISPC - Cumulative Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio iSpecimen Inc.|ISPC - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient ispecimen.com|ISPC - Company Debts|Debt to Book Value Ratio iSpecimen Corp|ISPC - Company Long-Term Debts|Company Current Liabilities iSpecimen|Interim Coverage Ratio ispecimen.com
- earnings and multiples data:
ISPC - Net Profit|Company Profit Forecast iSpecimen Inc.|ISPC - Price to Earnings Ratio|Market Cap to Projected Earnings ispecimen.com|ISPC - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio iSpecimen Corp|ISPC - Operating profit EBITDA|Net earnings per share for the last 12 months iSpecimen|ISPC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months ispecimen.com|ISPC - Net earnings per share growth this year|Projected earnings per share increase next year iSpecimen Inc.
- total revenue and sales volume data:
ISPC - Company Sales|Company Future Revenue ispecimen.com|ISPC - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple iSpecimen Corp
Fundamental company analysis:iSpecimen Inc (ISPC)
Finished products of iSpecimen Inc

The P/S ratio determines the market value of a business relative to its operating revenues, eliminating the impact of accounting manipulations regarding profit. By analyzing the price-to-sales ratio, an investor assesses the premium the market is willing to pay for every dollar of sales. This metric measures the efficiency of market share monetization and the pace of revenue scaling. For iSpecimen Inc. (ISPC), this indicator reflects the capitalization of the scientific community's trust in its unique biomaterials marketplace.

Competing companies

Price-to-Revenue Coefficient veeva.com|Price-to-Revenue Ratio Doximity DOCS|HQY - Market Cap to Revenue|Waystar Inc. - P/S Multiple|Price to Sales CorVel Corp.|Privia Health Group (PRVA) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio HURN|Market Cap to Revenue CERT|OMCL: Market Capitalization-to-Revenue Ratio|P/S Multiple GDRX|Price-to-Revenue Coefficient Schrodinger Corp|Price-to-Revenue Ratio Phreesia, Inc. PHR|OMDA: Market Cap to Revenue Ratio|Evolent Health - P/S Multiple|HealthStream Inc (HSTM) - Market Cap to Revenue|DH (Definitive Healthcare Inc.) - Market Cap to Revenue|CCSI - Price-to-Revenue Coefficient|AGL (Agilon Health) - P/S Multiple|absci.com (ABSI) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio So-Young International Inc. (SY)|Price-to-Revenue Coefficient NRC Health|Price-to-Revenue Ratio Spok Corp SPOK|OPRX (OptimizeRx Inc.) - Price-to-Sales Ratio|TruBridge, Inc. - P/S Multiple|simulations-plus.com (SLP) - Market Cap to Revenue|SOPH: P/S Multiple|HCAT - Price-to-Revenue Coefficient|Market Cap to Revenue CCLD|RSSS (Research Solutions Inc.) - Market Cap to Sales Volume|Market Cap to Revenue DLHC (DLH Holdings Corp.)|ONMD (onemednet.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Scienture SCNX|HCTI - Market Cap to Revenue|Bullfrog AI Holdings Inc - P/S Multiple|Price to Sales SCWorx Inc|MSPR: P/S Multiple|Market Cap to Revenue Ratio ICCT|MEDS (TRxADE HEALTH) - P/S Multiple|Orgenesis Inc (ORGS) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio R1 RCM Inc. (RCM)|Price-to-Revenue Coefficient Sharecare Inc|Price-to-Revenue Ratio Streamline Health Solutions STRM|SYRA (syrahealth.com) - Price-to-Sales Ratio|ApolloMed - P/S Multiple|Price to Sales Model N Inc|NXGN: P/S Multiple